InspireMD shares surge 12.36% after-hours after announcing inducement grants to eight new employees under 2024 Inducement Plan.

InspireMD surged 12.36% in after-hours trading following the announcement of inducement grants totaling 122,054 restricted shares to eight new non-executive employees under its 2024 Inducement Plan. The grants, approved November 20, 2025, are designed to attract talent and align with Nasdaq Listing Rule 5635(c)(4). The restricted stock vests over three years, with one-third vesting annually, subject to continued employment. Investors likely viewed the move as a strategic investment in workforce expansion, signaling confidence in the company’s growth prospects despite its ongoing operational challenges. The alignment of the stock’s upward movement with the positive implications of the grant announcement suggests market optimism about InspireMD’s ability to strengthen its team to advance its carotid stent technology commercialization.